Víctor Albarrán-Fernández

9PUBLICATIONS
26CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyPredictive and prognostic markersTumour immunologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 29, 2025
Unlocking the potential of engineered immune cell therapy for solid tumors.

Víctor Albarrán-Fernández, Laura Angelats, Julio Delgado

|Mar 14, 2024
Biomarkers for response to TIL therapy: a comprehensive review.

Víctor Albarrán Fernández, Pablo Ballestín Martínez, Joachim Stoltenborg Granhøj

|Sep 09, 2023
Recurrent Glioblastoma: A Review of the Treatment Options.

Maria Angeles Vaz-Salgado, María Villamayor, Víctor Albarrán

|May 16, 2023
Current Landscape of Immunotherapy for Advanced Sarcoma.

Víctor Albarrán, María Luisa Villamayor, Javier Pozas

|Dec 23, 2022
Androgen Receptor Signaling Inhibition in Advanced Castration Resistance Prostate Cancer: What Is Expected for the Near Future?

Javier Pozas, Sara Álvarez Rodríguez, Víctor Albarrán Fernández

|Nov 26, 2022
Receptor Tyrosine Kinase Inhibitors for the Treatment of Recurrent and Unresectable Bone Sarcomas.

Víctor Albarrán, María Luisa Villamayor, Jesús Chamorro

Pageof 2

Frequent Collaborators

4 joint publications

María San Román-Gil

3 joint publications

María Villamayor

2 joint publications

Javier Pozas

2 joint publications

Pablo Gajate